{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:25:09Z","timestamp":1775503509952,"version":"3.50.1"},"reference-count":104,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1136\/jnnp-2017-317509","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T07:20:09Z","timestamp":1522826409000},"page":"844-850","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":126,"title":["Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?"],"prefix":"10.1136","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-2775","authenticated-orcid":false,"given":"Jo\u00e3o J","family":"Cerqueira","sequence":"first","affiliation":[]},{"given":"D Alastair S","family":"Compston","sequence":"additional","affiliation":[]},{"given":"Ruth","family":"Geraldes","sequence":"additional","affiliation":[]},{"given":"Mario M","family":"Rosa","sequence":"additional","affiliation":[]},{"given":"Klaus","family":"Schmierer","sequence":"additional","affiliation":[]},{"given":"Alan","family":"Thompson","sequence":"additional","affiliation":[]},{"given":"Michela","family":"Tinelli","sequence":"additional","affiliation":[]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[]}],"member":"239","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"2020050722305557000_89.8.844.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3518"},{"key":"2020050722305557000_89.8.844.2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514561904"},{"key":"2020050722305557000_89.8.844.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-315238"},{"key":"2020050722305557000_89.8.844.4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2020050722305557000_89.8.844.5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh641"},{"key":"2020050722305557000_89.8.844.6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2324"},{"key":"2020050722305557000_89.8.844.7","first-page":"901","article-title":"Pathology of multiple sclerosis: where do we stand?","volume":"19","author":"Popescu","year":"2013","journal-title":"Continuum"},{"key":"2020050722305557000_89.8.844.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309903"},{"key":"2020050722305557000_89.8.844.9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e24136"},{"key":"2020050722305557000_89.8.844.10","doi-asserted-by":"crossref","unstructured":"Carassiti D , Altmann DR , Petrova N , et al . Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex. Neuropathol Appl Neurobiol 2017. doi:10.1111\/nan.12405","DOI":"10.1111\/nan.12405"},{"key":"2020050722305557000_89.8.844.11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws242"},{"key":"2020050722305557000_89.8.844.12","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514562440"},{"key":"2020050722305557000_89.8.844.13","doi-asserted-by":"publisher","DOI":"10.4161\/pri.23499"},{"key":"2020050722305557000_89.8.844.14","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hbm.23168","article-title":"Postmortem validation of MRI cortical volume measurements in MS","volume":"37","author":"Popescu","year":"2016","journal-title":"Hum Brain Mapp"},{"key":"2020050722305557000_89.8.844.15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf216"},{"key":"2020050722305557000_89.8.844.16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn096"},{"key":"2020050722305557000_89.8.844.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a8260a"},{"key":"2020050722305557000_89.8.844.18","unstructured":"Cadavid D , Edwards KR , Hupperts R , et al . Efficacy analysis of opicinumab in relapsing multiple sclerosis: the Phase 2b SYNERGY trial: ECTRIMS Online Library, 2016."},{"key":"2020050722305557000_89.8.844.19","unstructured":"Giovannoni G , Butzkueven H , Dhib-Jalbut S , et al . Brain health: time matters in multiple sclerosis. UK: Oxford PharmaGenesis, 2015."},{"key":"2020050722305557000_89.8.844.20","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513488235"},{"key":"2020050722305557000_89.8.844.21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.045518"},{"key":"2020050722305557000_89.8.844.22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31824528c9"},{"key":"2020050722305557000_89.8.844.23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f612e3"},{"key":"2020050722305557000_89.8.844.24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fneur.2015.00082","article-title":"Network collapse and cognitive impairment in multiple sclerosis","volume":"6","author":"Schoonheim","year":"2015","journal-title":"Front Neurol"},{"key":"2020050722305557000_89.8.844.25","first-page":"1352458517750767","article-title":"Cognitive reserve, cognition, and regional brain damage in MS: A 2\u2009-year longitudinal study","volume":"1","author":"Rocca","year":"2018","journal-title":"Mult Scler"},{"key":"2020050722305557000_89.8.844.26","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514554054"},{"key":"2020050722305557000_89.8.844.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535cf6"},{"key":"2020050722305557000_89.8.844.28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000541"},{"key":"2020050722305557000_89.8.844.29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e3973f"},{"key":"2020050722305557000_89.8.844.30","unstructured":"Kappos L , Bar-Or A , Cree B , et al . Efficacy and safety of siponimod in secondary progressive multiple sclerosis - Results of the placebo controlled, double-blind, Phase III EXPAND study: ECTRIMS Online Library, 2016."},{"key":"2020050722305557000_89.8.844.31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq076"},{"key":"2020050722305557000_89.8.844.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0934-5"},{"key":"2020050722305557000_89.8.844.33","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370108"},{"key":"2020050722305557000_89.8.844.34","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.241"},{"key":"2020050722305557000_89.8.844.35","first-page":"671","article-title":"Sustained disability improvement in patients with secondary progressive multiple sclerosis (SPMS) assessed by a multicomponent endpoint: a post hoc analysis from the ASCEND study","volume":"22","author":"Giovannoni","year":"2016","journal-title":"Multiple Sclerosis Journal"},{"key":"2020050722305557000_89.8.844.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606468"},{"key":"2020050722305557000_89.8.844.37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.msard.2017.01.007","article-title":"Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses","volume":"12","author":"Giovannoni","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"2020050722305557000_89.8.844.38","unstructured":"Patestas MA , Gartner LP . A textbook of neuroanatomy. US: John Wiley & Sons, 2016."},{"key":"2020050722305557000_89.8.844.39","doi-asserted-by":"crossref","unstructured":"Petrova N , Carassiti D , Altmann DR , et al . Axonal loss in the multiple sclerosis spinal cord revisited. Brain Pathol 2017. doi:10.1111\/bpa.12516","DOI":"10.1111\/bpa.12516"},{"key":"2020050722305557000_89.8.844.40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.msard.2015.02.003","article-title":"On the origin of EDSS","volume":"4","author":"Kurtzke","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"2020050722305557000_89.8.844.41","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1152\/jn.2001.86.5.2125","article-title":"Constraints on somatotopic organization in the primary motor cortex","volume":"86","author":"Schieber","year":"2001","journal-title":"J Neurophysiol"},{"key":"2020050722305557000_89.8.844.42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.5.679"},{"key":"2020050722305557000_89.8.844.43","unstructured":"Giovannoni G , Arnold DL , Bar-Or A , et al . An exploratory analysis of 12-and 24-week composite confirmed disability progression in patients with primary progressive multiple sclerosis in the ORATORIO trial. 2016 http:\/\/www.forskningsdatabasen.dk\/en\/catalog\/2347738993"},{"key":"2020050722305557000_89.8.844.44","unstructured":"Thomson A , Giovannoni G , Marta M , et al . \u00a0Importance of upper limb function in advanced MS: ECTRIMS, 2016."},{"key":"2020050722305557000_89.8.844.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606468"},{"key":"2020050722305557000_89.8.844.46","unstructured":"Giovanni G , Arnold DL , Bar-Or A , et al . An exploratory analysis of 12- and 24-week composite confirmed disability progression in patients with primary progressive multiple sclerosis in the ORATORIO trial. 2016 https:\/\/onlinelibrary.ectrims-congress.eu\/ectrims\/2016\/32nd\/146586\/gavin.giovannoni.an.exploratory.analysis.of.12-.and.24-week.composite.html?f=m3"},{"key":"2020050722305557000_89.8.844.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01314-8"},{"key":"2020050722305557000_89.8.844.48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/acn3.410","article-title":"Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis","volume":"4","author":"Alvarez-Gonzalez","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"2020050722305557000_89.8.844.49","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq076"},{"key":"2020050722305557000_89.8.844.50","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000317"},{"key":"2020050722305557000_89.8.844.51","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm038"},{"key":"2020050722305557000_89.8.844.52","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr182"},{"key":"2020050722305557000_89.8.844.53","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp070"},{"key":"2020050722305557000_89.8.844.54","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1177\/1352458517717811","article-title":"Disease modification in advanced MS: Focus on upper limb function","volume":"23","author":"Dubuisson","year":"2017","journal-title":"Mult Scler"},{"key":"2020050722305557000_89.8.844.55","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70131-9"},{"key":"2020050722305557000_89.8.844.56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(14)61622-6","article-title":"Simvastatin in patients with progressive multiple sclerosis--Authors' reply","volume":"384","author":"Chataway","year":"2014","journal-title":"Lancet"},{"key":"2020050722305557000_89.8.844.57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s13063-015-0953-1","article-title":"Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial","volume":"16","author":"Rice","year":"2015","journal-title":"Trials"},{"key":"2020050722305557000_89.8.844.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2015.04.006"},{"key":"2020050722305557000_89.8.844.59","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307721"},{"key":"2020050722305557000_89.8.844.60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601277"},{"key":"2020050722305557000_89.8.844.61","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1212\/NXI.0000000000000158","article-title":"No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine","volume":"2","author":"Pakpoor","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2020050722305557000_89.8.844.62","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2017.119","article-title":"Cladribine - an old newcomer for pulsed immune reconstitution in MS","volume":"13","author":"Wiendl","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2020050722305557000_89.8.844.63","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/WNL.0000000000004354","article-title":"Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings","volume":"89","author":"Coles","year":"2017","journal-title":"Neurology"},{"key":"2020050722305557000_89.8.844.64","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512451510"},{"key":"2020050722305557000_89.8.844.65","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh714"},{"key":"2020050722305557000_89.8.844.66","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511417479"},{"key":"2020050722305557000_89.8.844.67","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304333"},{"key":"2020050722305557000_89.8.844.68","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70256-X"},{"key":"2020050722305557000_89.8.844.69","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh714"},{"key":"2020050722305557000_89.8.844.70","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1042\/CS20170981","article-title":"Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis","volume":"131","author":"Martinez Sosa","year":"2017","journal-title":"Clin Sci"},{"key":"2020050722305557000_89.8.844.71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.24997","article-title":"Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex","volume":"82","author":"Yates","year":"2017","journal-title":"Ann Neurol"},{"key":"2020050722305557000_89.8.844.72","doi-asserted-by":"crossref","first-page":"aww258","DOI":"10.1093\/brain\/aww258","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"56","author":"Correale","year":"2016","journal-title":"Brain"},{"key":"2020050722305557000_89.8.844.73","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24497"},{"key":"2020050722305557000_89.8.844.74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ncl.2017.08.006","article-title":"Progressive forms of multiple sclerosis","volume":"36","author":"Zeydan","year":"2018","journal-title":"Neurol Clin"},{"key":"2020050722305557000_89.8.844.75","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.223"},{"key":"2020050722305557000_89.8.844.76","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000837"},{"key":"2020050722305557000_89.8.844.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.01.106"},{"key":"2020050722305557000_89.8.844.78","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12518"},{"key":"2020050722305557000_89.8.844.79","doi-asserted-by":"publisher","DOI":"10.1179\/1743132812Y.0000000051"},{"key":"2020050722305557000_89.8.844.80","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8295-9"},{"key":"2020050722305557000_89.8.844.81","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514564485"},{"key":"2020050722305557000_89.8.844.82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105207"},{"key":"2020050722305557000_89.8.844.83","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.2.260"},{"key":"2020050722305557000_89.8.844.84","doi-asserted-by":"crossref","unstructured":"Geraldes R , Esiri MM , DeLuca GC , et al . Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis. Brain Pathol 2017;27. doi:10.1111\/bpa.12460","DOI":"10.1111\/bpa.12460"},{"key":"2020050722305557000_89.8.844.85","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.berh.2016.10.006","article-title":"Cardiovascular disease in inflammatory rheumatic diseases","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2020050722305557000_89.8.844.86","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.0000000000002481","article-title":"Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"key":"2020050722305557000_89.8.844.87","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt139"},{"key":"2020050722305557000_89.8.844.88","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d6b125"},{"key":"2020050722305557000_89.8.844.89","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gister\u00e5","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2020050722305557000_89.8.844.90","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513495936"},{"key":"2020050722305557000_89.8.844.91","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv398"},{"key":"2020050722305557000_89.8.844.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.06.018"},{"key":"2020050722305557000_89.8.844.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2009.12.012"},{"key":"2020050722305557000_89.8.844.94","first-page":"135245851773614","article-title":"The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis","volume":"87","author":"Pichler","year":"2017","journal-title":"Mult Scler"},{"key":"2020050722305557000_89.8.844.95","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","article-title":"Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study","volume":"89","author":"Kowalec","year":"2017","journal-title":"Neurology"},{"key":"2020050722305557000_89.8.844.96","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/bpa.12460","article-title":"Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis","volume":"27","author":"Geraldes","year":"2017","journal-title":"Brain Pathol"},{"key":"2020050722305557000_89.8.844.97","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316011"},{"key":"2020050722305557000_89.8.844.98","doi-asserted-by":"crossref","unstructured":"Tanasescu R , Constantinescu CS , Tench CR , et al . Smoking cessation and the reduction of disability progression in Multiple Sclerosis: a cohort study. Nicotine Tob Res 2017. doi:10.1093\/ntr\/ntx084","DOI":"10.1093\/ntr\/ntx084"},{"key":"2020050722305557000_89.8.844.99","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/1352458517694432","article-title":"New insights into the burden and costs of multiple sclerosis in Europe","volume":"23","author":"Kobelt","year":"2017","journal-title":"Mult Scler"},{"key":"2020050722305557000_89.8.844.100","unstructured":"Tinelli M , Kanavos P . Using IMPrESS (International MultiPlE Sclerosis Study) to guide policy change in multiple sclerosis. Multiple Sclerosis Journal. In Press."},{"key":"2020050722305557000_89.8.844.101","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000768"},{"key":"2020050722305557000_89.8.844.102","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3079"},{"key":"2020050722305557000_89.8.844.103","unstructured":"WHO. ICIDH-2: International classification of functioning, disability and health. Geneva, Switzerland: WHO, 2001."},{"key":"2020050722305557000_89.8.844.104","unstructured":"National Institute for Health and Care Excellence. Guide to the processes of technology appraisal. 2014 https:\/\/www.nice.org.uk\/process\/pmg19\/chapter\/selection-of-technologies"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2017-317509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:09:30Z","timestamp":1601057370000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2017-317509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":104,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,7,12]]},"published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1136\/jnnp-2017-317509"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2017-317509","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]}}}